1. Home
  2. FURY vs HYFT Comparison

FURY vs HYFT Comparison

Compare FURY & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fury Gold Mines Limited

FURY

Fury Gold Mines Limited

HOLD

Current Price

$0.61

Market Cap

97.7M

ML Signal

HOLD

HYFT

MindWalk Holdings Corp.

N/A

Current Price

$1.64

Market Cap

80.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FURY
HYFT
Founded
2008
1983
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
97.7M
80.8M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
FURY
HYFT
Price
$0.61
$1.64
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$1.40
N/A
AVG Volume (30 Days)
663.8K
371.0K
Earning Date
11-13-2025
12-15-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$19,019,110.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$71.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
49.46
52 Week Low
$0.35
$0.27
52 Week High
$0.89
$3.25

Technical Indicators

Market Signals
Indicator
FURY
HYFT
Relative Strength Index (RSI) 52.05 N/A
Support Level $0.58 N/A
Resistance Level $0.72 N/A
Average True Range (ATR) 0.05 0.00
MACD 0.00 0.00
Stochastic Oscillator 26.52 0.00

Price Performance

Historical Comparison
FURY
HYFT

About FURY Fury Gold Mines Limited

Fury Gold Mines Ltd is a Canadian-focused exploration and development company strategically positioned in three prolific mining regions: James Bay, Quebec; the Golden Triangle, British Columbia; and the Kitikmeot Region Nunavut. Its projects include Eau Claire, Homestake Ridge, Committee Bay, Eleonore South JV, and Gibson MacQuoid.

About HYFT MindWalk Holdings Corp.

MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.

Share on Social Networks: